EUVIMEDEUVIMED entdecken
Crossref

Ataxia telangiectasia and Rad3-related (ATR) inhibition by VE-822 potently reversed 5-flourouracil resistance in colorectal cancer cells through targeting DNA damage response

Ainaz Mihanfar, Faezeh Asghari, Maryam Majidinia

Molecular Biology Reports · 2024-12 · 51 (1)

DOI: 10.1007/s11033-024-09431-7 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Molecular Biology Reports, online erschienen am 29.03.2024. Verfasst von Ainaz Mihanfar und 2 weiteren Autor:innen. Beteiligte Einrichtung: Solid Tumor Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran. Hauptthemen laut MEDLINE: Ataxia Telangiectasia, Colorectal Neoplasms, Isoxazoles, Pyrazines. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 34 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: VE-822 is a novel inhibitor of ATR, a key kinase involved in the DNA damage response pathway. The role of ATR inhibition in reversing drug resistance in various cancer types has been investigated. Therefore, this study investigated the effects of ATR inhibition by VE-822 on reversing 5-fluorouracil (5-FU) resistance in colorectal cancer cell line (Caco-2). METHODS: Caco-2 and 5-FU resistance Caco-2 (Caco-2/5-FU) cells were treated with 5-FU and VE-822, alone and in combination. Cell proliferation and viability were assessed by MTT assay and Trypan Blue staining. P-glycoprotein (P-gp) and multidrug resistance-associated protein 1 (MRP1) activities were measured by Rhodamine123 accumulation and uptake assay. The mRNA levels of P-gp, MRP-1, ataxia telangiectasia and Rad3-related (ATR) and checkpoint kinase 1 (CHK1) were measured by qRT-PCR. Western blot was used to measure the protein levels of P-gp, MRP-1, γ-H2AX, ATR and CHK1 in cells. 8-Oxo-2'-deoxyguanosine (8-oxo-dG) levels were determined via ELISA. Apoptosis was evaluated by ELISA death assay, DAPI staining and lactate dehydrogenase (LDH) assay. RESULTS: The Caco-2/5-FU cells showed lower levels of 5-FU mediated proliferation inhibition in comparison to Caco-2 cells. VE-822 decreased the IC50 value of 5-FU on resistant cells. In addition, the expression levels and activity of P-gp and MRP-1 were significantly decreased in resistant cells treated with VE-822 (P < 0.05). The combination of 5-FU and VE-822 increased apoptosis in Caco-2/5-FU cells by downregulating CHK1 and ATR and upregulating γ-H2AX and 8-oxo-dG. CONCLUSION: The simultaneous treatment of resistant colorectal cancer cells with 5-FU and ATR inhibitor, VE-822, was demonstrated to be effective in reversing drug resistance and potentiating 5-FU mediated anticancer effects via targeting DNA damage.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Ataxia TelangiectasiaColorectal NeoplasmsIsoxazolesPyrazinesHumansCell Line, TumorCaco-2 Cells8-Hydroxy-2'-DeoxyguanosineAtaxia Telangiectasia Mutated ProteinsFluorouracilDNA DamageDNA Repair

Stichwörter der Autor:innen

5-FUATRCHK1Colorectal cancerDrug resistanceVE-822

Substanzen

berzosertib8-Hydroxy-2'-DeoxyguanosineAtaxia Telangiectasia Mutated ProteinsFluorouracilATR protein, humanIsoxazolesPyrazines

Autor:innen und Institutionen

  • Solid Tumor Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran.
  • Immunology Department, Faculty of Medical Sciences, Tarbiat Modares University, Tehran, Iran.
  • Solid Tumor Research Center, Cellular and Molecular Medicine Institute, Urmia University of Medical Sciences, Urmia, Iran. majidinia.m@umsu.ac.ir.

Zitieren

APA

Mihanfar, A., Asghari, F., & Majidinia, M. (2024). Ataxia telangiectasia and Rad3-related (ATR) inhibition by VE-822 potently reversed 5-flourouracil resistance in colorectal cancer cells through targeting DNA damage response. Molecular Biology Reports, 51(1). https://doi.org/10.1007/s11033-024-09431-7

Vancouver

Mihanfar A, Asghari F, Majidinia M. Ataxia telangiectasia and Rad3-related (ATR) inhibition by VE-822 potently reversed 5-flourouracil resistance in colorectal cancer cells through targeting DNA damage response. Molecular Biology Reports. 2024;51(1). doi:10.1007/s11033-024-09431-7

BibTeX
@article{Mihanfar2024,
  author = {Mihanfar, Ainaz and Asghari, Faezeh and Majidinia, Maryam},
  title = {Ataxia telangiectasia and Rad3-related (ATR) inhibition by VE-822 potently reversed 5-flourouracil resistance in colorectal cancer cells through targeting DNA damage response},
  journal = {Molecular Biology Reports},
  year = {2024},
  volume = {51},
  number = {1},
  doi = {10.1007/s11033-024-09431-7}
}
Kostenlos starten →